Cargando…

Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes

Detalles Bibliográficos
Autor principal: Vranic, Semir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113938/
https://www.ncbi.nlm.nih.gov/pubmed/36786279
http://dx.doi.org/10.17305/bb.2022.8874
_version_ 1785027925012119552
author Vranic, Semir
author_facet Vranic, Semir
author_sort Vranic, Semir
collection PubMed
description
format Online
Article
Text
id pubmed-10113938
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format MEDLINE/PubMed
spelling pubmed-101139382023-04-20 Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes Vranic, Semir Biomol Biomed Editorial Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023-04-01 2023-03-16 /pmc/articles/PMC10113938/ /pubmed/36786279 http://dx.doi.org/10.17305/bb.2022.8874 Text en © 2023 Vranic. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Vranic, Semir
Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
title Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
title_full Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
title_fullStr Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
title_full_unstemmed Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
title_short Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
title_sort sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113938/
https://www.ncbi.nlm.nih.gov/pubmed/36786279
http://dx.doi.org/10.17305/bb.2022.8874
work_keys_str_mv AT vranicsemir sacituzumabgovitecanexpandsitstherapeuticspectrumamongbreastcancersubtypes